Prime Medicine, Inc. · NASDAQ:PRME
Newpath Partners, L.P.'s stake in Prime Medicine, Inc. fell to 4.70% (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 14, 2025
Newpath Partners, L.P.'s stake in Prime Medicine, Inc. fell to 4.70%, 6,105,679 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).
- Stake
- 4.70%
- Shares
- 6,105,679
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Newpath Partners, L.P. | 4.70% | 6,105,679 |
| Newpath Partners GP, L.P. | 4.70% | 6,105,679 |
| Newpath Partners GP, LLC | 4.70% | 6,105,679 |
| Thomas Cahill | 4.70% | 6,105,679 |
Source
Related
- Prime Medicine, Inc.
- Newpath Partners, L.P.
- Prime Medicine, Inc. shareholders
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · Feb 17, 2026
- Schedule 13G · T. Rowe Price Investment Management, Inc. · Nov 14, 2025
- Schedule 13G/A · Alphabet Holdings LLC · Nov 12, 2025
- Schedule 13G/A · FMR LLC · Nov 5, 2025
- Schedule 13D/A · ARCH Venture Fund X, L.P. · Aug 11, 2025